Cite
HARVARD Citation
Schwab, I. et al. (n.d.). Broad requirement for terminal sialic acid residues and FcγRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo. European journal of immunology. 44 (5), pp. 1444-1453. [Online].